Header image

Session 9D: Built to compete: Manufacturing as Australia's strategic advantage

Tracks
Track 4
Friday, October 23, 2026
11:30 AM - 12:15 PM
Industry & Ecosystems Breakout Room

Details

Manufacturing has become far more than the final step in product development. Today, it shapes investment decisions, influences commercialisation strategies and determines how quickly new therapies and technologies reach patients around the world. As Australia builds world-class capability across advanced therapeutics, biologics, medical technologies and precision manufacturing, the challenge is not to do everything ourselves, but to focus on the areas where Australia can lead globally while leveraging trusted international partnerships and resilient supply chains. This discussion explores how Australia can strengthen sovereign capability through a nationally connected manufacturing ecosystem, creating competitive advantage while remaining an integral part of global value chains. Discover why manufacturing is emerging as a strategic driver of innovation, investment and resilience, and how Australia can position itself as a globally trusted partner in the future of life sciences value chain.


Speaker

Agenda Item Image
Mr Adam Cias
Manufacturing Manager
Orthocell

Panellist

Agenda Item Image
Prof. Ulrike Fiedler
Strategic Advisor
BioCina

Panellist

Agenda Item Image
Dr Daniel Getts
Director
Aurora Biosynthetics

Panellist

Agenda Item Image
Karyn McIntosh
Director Government & Policy
AusBiotech Ltd

Chair

Agenda Item Image
Dr. Felicia Pradera
Director, Regional Research Centre and Strategic Alliances
Moderna

Panellist

Agenda Item Image
Mrs Katie Wood
Director, Head of Frontline Quality Assurance
CSL Sequirus

Panellist

loading